Mohell N, Svartengren J, Cannon B
Eur J Pharmacol. 1983 Aug 19;92(1-2):15-25. doi: 10.1016/0014-2999(83)90103-6.
The alpha 1-receptor selective adrenergic antagonist [3H]prazosin was used to study adrenergic binding sites in crude membranes and isolated cells from hamster brown adipose tissue. The antagonist labelled a site which fulfilled the criteria for being the alpha 1-receptor which participates in mediation of a part of the norepinephrine-induced respiration (thermogenesis) in intact cells. The similarity between the characteristics of the binding site in crude membrane fractions and in isolated brown fat cells suggested that the site is of postsynaptic origin. In equilibrium binding studies [3H]prazosin bound with very high affinity (Kd = 0.4 nM), and the maximal binding capacity was 72 fmol/mg protein and 207 fmol/10(6) cells, equal to 120 000 receptors per cell. The kinetically calculated Kd had a value of 0.17 nM, in good agreement with that determined in the equilibrium binding experiments. The relative potencies of adrenergic agents to displace [3H]prazosin revealed a typical alpha 1-specificity: WB-4101 = prazosin greater than phentolamine greater than dihydroergocryptine much greater than yohimbine greater than propranolol for antagonists, and L-phenylephrine = L-norepinephrine = L-epinephrine greater than L-isoprenaline greater than D-norepinephrine for agonists. Thus stereoselectivity was also shown. The actual Ki values for antagonists were closely similar in crude membranes and isolated cells whereas the alpha 1-receptor showed a 10-20 times higher affinity for agonists in the cellular preparation than in the crude membranes. The Ki values for the different antagonists and agonists derived from binding studies in isolated cells were compared with the IC50 and EC50 values for these agents obtained from studies on alpha 1-mediated cellular effects. It is suggested that tight coupling exists between alpha 1-receptor occupancy and alpha 1-mediated effects.
α1受体选择性肾上腺素能拮抗剂[3H]哌唑嗪被用于研究仓鼠棕色脂肪组织粗膜和分离细胞中的肾上腺素能结合位点。该拮抗剂标记了一个符合α1受体标准的位点,该受体参与完整细胞中去甲肾上腺素诱导的部分呼吸作用(产热)的介导。粗膜组分和分离的棕色脂肪细胞中结合位点的特征相似,表明该位点起源于突触后。在平衡结合研究中,[3H]哌唑嗪以非常高的亲和力结合(Kd = 0.4 nM),最大结合容量为72 fmol/mg蛋白质和207 fmol/10(6)个细胞,相当于每个细胞120000个受体。动力学计算的Kd值为0.17 nM,与平衡结合实验中测定的值高度一致。肾上腺素能药物取代[3H]哌唑嗪的相对效力显示出典型的α1特异性:对于拮抗剂,WB-4101 = 哌唑嗪 > 酚妥拉明 > 双氢麦角隐亭 >> 育亨宾 > 普萘洛尔;对于激动剂,L-去氧肾上腺素 = L-去甲肾上腺素 = L-肾上腺素 > L-异丙肾上腺素 > D-去甲肾上腺素。因此也表现出立体选择性。拮抗剂的实际Ki值在粗膜和分离细胞中非常相似,而α1受体对激动剂的亲和力在细胞制剂中比在粗膜中高10 - 20倍。将分离细胞结合研究中不同拮抗剂和激动剂的Ki值与这些药物在α1介导的细胞效应研究中获得的IC50和EC50值进行比较。提示α1受体占据与α1介导的效应之间存在紧密偶联。